Rulemaking action by the Iowa Board of Pharmacy has been published in the Iowa Administrative Bulletin as follows:
Adoption
- ARC 8175C has been adopted and filed to amend Chapter 10, “Controlled Substances.”
- The amendment temporarily places nine substances into Schedule I of the Iowa CSA in response to similar action taken by the federal DEA.
- The amendment is effective September 11, 2024.
- ARC 8176C has been adopted and filed to amend Chapter 10, “Controlled Substances.”
- The amendment temporarily places one substance into Schedule I of the Iowa CSA in response to similar action taken by the federal DEA.
- The amendment is effective September 11, 2024.
Regulatory Analysis
- A regulatory analysis has been published on proposed new 481 Chapter 550, “Definitions,” and Chapter 551, “Licenses, Registrations, and Permits.”
- The regulatory analysis proposes to establish two new chapters to provide definitions to be applicable in 481 Chapters 550 through 557 and the requirements for a license, registration or permit from the Board of Pharmacy.
- Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
- A public hearing will be held August 29, 2024 at 1:00 p.m.
- A regulatory analysis has been published on proposed new 481 Chapter 552, “Standards - Practice of Pharmacy.”
- The regulatory analysis proposes to establish this chapter to provide standards and requirements for the practice of pharmacy in the state of Iowa.
- Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
- A public hearing will be held August 29, 2024 at 1:30 p.m.
- A regulatory analysis has been published on proposed new 481 Chapter 553, “Controlled and Precursor Substances.”
- The regulatory analysis proposes to establish this chapter to provide standards and requirements for controlled and precursor substances.
- Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
- A public hearing will be held August 29, 2024 at 2:00 p.m.
- A regulatory analysis has been published on proposed new 481 Chapter 554, “Operational Standards - Distribution and Drug Supply Chain.”
- The regulatory analysis proposes to establish this chapter to provide standards and requirements for entities within the drug supply chain.
- Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
- A public hearing will be held August 29, 2024 at 2:30 p.m.
- A regulatory analysis has been published on proposed new 481 Chapter 555, “Standards - Drugs in EMS Programs.”
- The regulatory analysis proposes to establish this chapter to provide standards and requirements for the utilization of drugs in EMS programs.
- Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
- A public hearing will be held August 29, 2024 at 2:45 p.m.
- A regulatory analysis has been published on proposed new 481 Chapter 556, “Iowa Prescription Monitoring Program.”
- The regulatory analysis proposes to establish this chapter to provide information about the Iowa Prescription Monitoring Program.
- Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
- A public hearing will be held August 29, 2024 at 3:00 p.m.
- A regulatory analysis has been published on proposed new 481 Chapter 557, “Board Operations.”
- The regulatory analysis proposes to establish this chapter to provide information about the Board of Pharmacy operations.
- Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
- A public hearing will be held August 29, 2024 at 3:30 p.m.